These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33045631)

  • 1. Lack of protection against feline immunodeficiency virus infection among domestic cats in New Zealand vaccinated with the Fel-O-Vax® FIV vaccine.
    Stickney A; Ghosh S; Cave NJ; Dunowska M
    Vet Microbiol; 2020 Nov; 250():108865. PubMed ID: 33045631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats.
    Kusuhara H; Hohdatsu T; Okumura M; Sato K; Suzuki Y; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
    Vet Microbiol; 2005 Jul; 108(3-4):155-65. PubMed ID: 15899558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV) infection: an update for clinicians.
    Westman ME; Malik R; Norris JM
    Aust Vet J; 2019 Mar; 97(3):47-55. PubMed ID: 30809813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feline immunodeficiency virus (FIV) infection in domestic pet cats in Australia and New Zealand: Guidelines for diagnosis, prevention and management.
    Westman ME; Coggins SJ; van Dorsselaer M; Norris JM; Squires RA; Thompson M; Malik R
    Aust Vet J; 2022 Aug; 100(8):345-359. PubMed ID: 35578381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of antibody response following vaccination against feline immunodeficiency virus.
    Westman ME; Malik R; Hall E; Harris M; Hosie MJ; Norris JM
    J Feline Med Surg; 2017 Oct; 19(10):1055-1064. PubMed ID: 27770018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody Responses in Cats Following Primary and Annual Vaccination against Feline Immunodeficiency Virus (FIV) with an Inactivated Whole-Virus Vaccine (Fel-O-Vax
    Westman M; Yang D; Green J; Norris J; Malik R; Parr YA; McDonald M; Hosie MJ; VandeWoude S; Miller C
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33809232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate.
    Pu R; Coleman J; Coisman J; Sato E; Tanabe T; Arai M; Yamamoto JK
    J Feline Med Surg; 2005 Feb; 7(1):65-70. PubMed ID: 15686976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccine.
    Bęczkowski PM; Harris M; Techakriengkrai N; Beatty JA; Willett BJ; Hosie MJ
    Vaccine; 2015 Feb; 33(8):977-84. PubMed ID: 25613718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological differentiation of FIV-infected cats from dual-subtype feline immunodeficiency virus vaccine (Fel-O-Vax FIV) inoculated cats.
    Kusuhara H; Hohdatsu T; Seta T; Nemoto K; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
    Vet Microbiol; 2007 Mar; 120(3-4):217-25. PubMed ID: 17141431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon.
    Gupta S; Leutenegger CM; Dean GA; Steckbeck JD; Cole KS; Sparger EE
    J Virol; 2007 Jan; 81(2):465-73. PubMed ID: 17079309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of a feline immunodeficiency virus vaccine.
    Huang C; Conlee D; Loop J; Champ D; Gill M; Chu HJ
    Anim Health Res Rev; 2004 Dec; 5(2):295-300. PubMed ID: 15984343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of feline immunodeficiency virus vaccination, infection, or vaccination and infection in cats.
    Levy JK; Crawford PC; Kusuhara H; Motokawa K; Gemma T; Watanabe R; Arai S; Bienzle D; Hohdatsu T
    J Vet Intern Med; 2008; 22(2):330-4. PubMed ID: 18371028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge.
    Huang C; Conlee D; Gill M; Chu HJ
    J Feline Med Surg; 2010 Jun; 12(6):451-7. PubMed ID: 20167521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons Learned in Developing a Commercial FIV Vaccine: The Immunity Required for an Effective HIV-1 Vaccine.
    Sahay B; Yamamoto JK
    Viruses; 2018 May; 10(5):. PubMed ID: 29789450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protective rate of the feline immunodeficiency virus vaccine: An Australian field study.
    Westman ME; Malik R; Hall E; Harris M; Norris JM
    Vaccine; 2016 Sep; 34(39):4752-4758. PubMed ID: 27522177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence variation of the feline immunodeficiency virus genome and its clinical relevance.
    Stickney AL; Dunowska M; Cave NJ
    Vet Rec; 2013 Jun; 172(23):607-14. PubMed ID: 23749359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feline immunodeficiency virus model for designing HIV/AIDS vaccines.
    Yamamoto JK; Sanou MP; Abbott JR; Coleman JK
    Curr HIV Res; 2010 Jan; 8(1):14-25. PubMed ID: 20210778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection.
    Hofmann-Lehmann R; Holznagel E; Aubert A; Ossent P; Reinacher M; Lutz H
    Vet Immunol Immunopathol; 1995 May; 46(1-2):127-37. PubMed ID: 7618252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosing feline immunodeficiency virus (FIV) infection in FIV-vaccinated and FIV-unvaccinated cats using saliva.
    Westman ME; Malik R; Hall E; Norris JM
    Comp Immunol Microbiol Infect Dis; 2016 Jun; 46():66-72. PubMed ID: 27260813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins.
    Leutenegger CM; Hofmann-Lehmann R; Holznagel E; Cuisinier AM; Wolfensberger C; Duquesne V; Cronier J; Allenspach K; Aubert A; Ossent P; Lutz H
    AIDS Res Hum Retroviruses; 1998 Feb; 14(3):275-83. PubMed ID: 9491919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.